awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36774217-CBB9BC31-AE08-4835-97B5-E2A38313B338
Q36774217-CBB9BC31-AE08-4835-97B5-E2A38313B338
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36774217-CBB9BC31-AE08-4835-97B5-E2A38313B338
Polymorphisms in thymidylate synthase and reduced folate carrier (SLC19A1) genes predict survival outcome in advanced non-small cell lung cancer patients treated with pemetrexed-based chemotherapy.
P2860
Q36774217-CBB9BC31-AE08-4835-97B5-E2A38313B338
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36774217-CBB9BC31-AE08-4835-97B5-E2A38313B338
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b03d305d2aca7b55ec22b347fa676e8715caf94e
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.